Covid-19: Ghana approves first herbal drug for clinical trial

– – Ghana’s Food and Drugs Authority (FDA) has announced that it has given approval for the country’s first herbal medicine Cryptolepis Sanguinolenta locally known as Nibima for clinical trials for the treatment of Covid-19. The herbal medicine went through several laboratory studies at one of the country’s major university research centre called the Kwame Nkrumah University of Science and Technology (KNUST). The research team at the institution said the drug showed signs of efficacy against the coronavirus. With the backing of Ghana’s National Medicine Regulatory Agency (NMRA) the FDA…

Read More